• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 1
  • 1
  • Tagged with
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
1

Evaluierung eines Modellsystems unter Nutzung der Thy–1/Thy–1 – Ligand Interaktion zur Testung anti – inflammatorischer Substanzen

Molkenthin, geb. Schubert, Claudia 23 December 2016 (has links) (PDF)
Schubert K., Polte T., Bönisch U., Schader S., Holtappels R., Hildebrandt G., Lehmann J., Simon J.C., Anderegg U., Saalbach A. Thy-1 (CD90) regulates the extravasation of leukocytes during inflammation. Eur. J. Immunol. 41, 2011; 645-656 / Saalbach A, Haustein UF, and Anderegg U. A ligand of human Thy-1 is localized on polymorphonuclear leukocytes and monocytes and mediates the binding to activated Thy-1 positive microvascular endothelial cells and fibroblasts. J. Invest. Dermatol. 2000; 115: 882-888 / Wetzel A., Wetzig T., Haustein U.F., Sticherling M., Anderegg U., Simon J.C., Saalbach A. Increased Neutrophil Adherence in Psoriasis: Role of the Human Endothelial Cell Receptor Thy-1 (CD90). Journal of Investigative Dermatology. 2006; 126: 441–452 / Saalbach A., Arnhold J., Leßig J., Simon J. C., Anderegg U. Human Thy-1 induces secretion of matrixmetalloproteinase-9 and CXCL8 from human neutrophils. Eur. J. Immunol. 2008; 38: 1391–1403 / Schmidt M., Gutknecht D., Simon J.C., Schulz J.N., Eckes B., Anderegg U., Saalbach A. Controlling the Balance of Fibroblast Proliferation and Differentiation: Impact of Thy-1. J Invest Dermatol. 2015; 135(7):1893-902 / Saalbach, A., Wetzig, T., Haustein, U.F., and Anderegg, U. Detection of human soluble Thy-1 in serum by ELISA: fibroblasts and activated endothelial cells are a possible source of soluble Thy-1 in serum. Cell Tiss. Res. 1999; 298: 307-315 / Wetzel A, Chavakis T, Preissner K, Sticherling M, Haustein U-F, Anderegg U, Saalbach A. Human Thy-1 (CD90) on Activated Endothel Cells is a Counterreceptor for the Leucocyte Integrin Mac-1 (CD11b/CD18). The Journal of Immunology 2004; 172: 3850-3859
2

Evaluierung eines Modellsystems unter Nutzung der Thy–1/Thy–1 – Ligand Interaktion zur Testung anti – inflammatorischer Substanzen: Evaluierung eines Modellsystems unter Nutzung derThy–1/Thy–1 – Ligand Interaktion zur Testunganti – inflammatorischer Substanzen

Molkenthin, geb. Schubert, Claudia 06 December 2016 (has links)
Schubert K., Polte T., Bönisch U., Schader S., Holtappels R., Hildebrandt G., Lehmann J., Simon J.C., Anderegg U., Saalbach A. Thy-1 (CD90) regulates the extravasation of leukocytes during inflammation. Eur. J. Immunol. 41, 2011; 645-656 / Saalbach A, Haustein UF, and Anderegg U. A ligand of human Thy-1 is localized on polymorphonuclear leukocytes and monocytes and mediates the binding to activated Thy-1 positive microvascular endothelial cells and fibroblasts. J. Invest. Dermatol. 2000; 115: 882-888 / Wetzel A., Wetzig T., Haustein U.F., Sticherling M., Anderegg U., Simon J.C., Saalbach A. Increased Neutrophil Adherence in Psoriasis: Role of the Human Endothelial Cell Receptor Thy-1 (CD90). Journal of Investigative Dermatology. 2006; 126: 441–452 / Saalbach A., Arnhold J., Leßig J., Simon J. C., Anderegg U. Human Thy-1 induces secretion of matrixmetalloproteinase-9 and CXCL8 from human neutrophils. Eur. J. Immunol. 2008; 38: 1391–1403 / Schmidt M., Gutknecht D., Simon J.C., Schulz J.N., Eckes B., Anderegg U., Saalbach A. Controlling the Balance of Fibroblast Proliferation and Differentiation: Impact of Thy-1. J Invest Dermatol. 2015; 135(7):1893-902 / Saalbach, A., Wetzig, T., Haustein, U.F., and Anderegg, U. Detection of human soluble Thy-1 in serum by ELISA: fibroblasts and activated endothelial cells are a possible source of soluble Thy-1 in serum. Cell Tiss. Res. 1999; 298: 307-315 / Wetzel A, Chavakis T, Preissner K, Sticherling M, Haustein U-F, Anderegg U, Saalbach A. Human Thy-1 (CD90) on Activated Endothel Cells is a Counterreceptor for the Leucocyte Integrin Mac-1 (CD11b/CD18). The Journal of Immunology 2004; 172: 3850-3859

Page generated in 0.1528 seconds